Anylam reports Patisiran revenues of $38 million for the quarter | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34699 of 34708  at  8/8/2019 5:54:09 PM  by

The Rooster


Anylam reports Patisiran revenues of $38 million for the quarter

 
Seems Patisiran revenues are starting to hit their stride with $38 million in Q2.  Plus Alnylam seems to be about ready to start a phase III for Patisiran with cardiomyopathy (they say it is start to mid-2019).


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 4     Views: 241
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...